There are no modern clinical data for determining the incidence of side effects. Their frequency may vary depending on the dose and on whether the drug was administered as monotherapy or in combination with other drugs. Classification of frequency of side effects is based on a rough estimate, for the majority of side effects no data to determine the frequency of their development.
Classification of adverse reactions depending on frequency of occurrence is as follows: very frequent (≥1/10), frequent (from ≥1 / 100 to <1/10), infrequent (from ≥1 / 1000 to <1/100), rare (from ≥1 / 10000 to <1/1000), very rare (<1/10000), frequency unknown (can not be determined from the available data).
The undesirable reactions associated with allopurinol therapy observed in the postgrade period are rare or very rare.In the general population of patients, in most cases, are of an easy nature. The incidence of adverse events increases with impaired renal and / or liver function.
Infections and parasitic diseases: very rare - furunculosis.
Disturbances from the blood system and lymphatic system: very rare - agranulocytosis, aplastic anemia, thrombocytopenia, granulocytosis, leukopenia, leukocytosis, eosinophilia and aplasia, relating only to erythrocytes.
Rarely there have been reports of thrombocytopenia, agranulocytosis and aplastic anemia, especially in persons with impaired renal and / or liver function, which emphasizes the need for special caution in these patient groups.
Immune system disorders: infrequent hypersensitivity reactions; rare - severe hypersensitivity reactions, including skin reactions with epidermal detachment, fever, lymphadenopathy, arthralgia, and / or eosinophilia (including Stevens-Johnson syndrome and toxic epidermal necrolysis) (see "Skin and subcutaneous tissue disorders" section). Concomitant vasculitis or reactions from the side of the tissue can have various manifestations, including hepatitis, kidney damage, acute cholangitis, xanthine calculi and,in very rare cases, convulsions. Besides, rarely the development of anaphylactic shock was observed. With the development of severe adverse reactions, allopurinol therapy immediately stop and do not resume. With delayed multi-organ hypersensitivity (known as drug hypersensitivity /DRESS/) the following symptoms can develop in different combinations: fever, skin rash, vasculitis, lymphadenopathy, pseudolymphoma, arthralgia, leukopenia, eosinophilia, hepatosplenomegaly, changes in liver function tests, disappearing bile duct syndrome (intrahepatic bile duct destruction or disappearance). With the development of such reactions in any period of treatment, Allopurinol should be immediately canceled and never renewed. Generalized hypersensitivity reactions developed in patients with impaired renal and / or liver function. Such cases were sometimes fatal; very rare - angioimmunoblastic lymphadenopathy.
Angioimmunoblastic lymphadenopathy was very rarely diagnosed after lymph node biopsy for generalized lymphadenopathy.Angioimmunoblastic lymphadenopathy is reversible and regresses after cessation of therapy with allopurinol.
Disorders from the metabolism and nutrition: very rare - Diabetes mellitus, hyperlipidemia.
Disorders of the psyche: very rare - depression.
Disorders from the nervous system: very rare - coma, paralysis, ataxia, neuropathy, paresthesia, drowsiness, headache, perversion of taste sensations.
Disorders from the side of the organ of vision: very rare - cataract, visual impairment, macular changes.
Hearing disorders and labyrinthine disorders: very rare - dizziness (vertigo).
Disorders from the heart: very rare - angina, bradycardia.
Vascular disorders: very rare - Increased blood pressure.
Disorders from the gastrointestinal tract: infrequent - vomiting, nausea, diarrhea.
In previous clinical studies, nausea and vomiting have been observed, but later observations confirmed that these reactions are not a clinically significant problem and can be avoided by prescribing allopurinol after meal; very rare - recurrent bloody vomiting, steatorrhea, stomatitis, changes in the frequency of defecation; frequency unknown - abdominal pain.
Disorders from the liver and bile ducts: infrequent - asymptomatic increase in the concentration of hepatic enzymes (elevated levels of alkaline phosphatase and transaminases in blood serum); rare - Hepatitis (including necrotic and granulomatous forms). Dysfunction of the liver can develop without obvious signs of generalized hypersensitivity
Disturbances from the skin and subcutaneous tissues: frequent - rash; rare - severe reactions from the skin: Stevens-Johnson syndrome (SDS) and toxic epidermal necrolysis (TEN); very rare - angioedema, local medication rash, alopecia, hair discoloration.
In patients receiving allopurinol, the most common adverse reactions from the skin. Against the background of drug therapy, these reactions can develop at any time. Skin reactions can be manifested by itching, maculopapular and scaly rashes. In other cases purple may develop. In rare cases, exfoliative skin lesions are observed (SSD / TEN). With the development of such reactions, therapy with allopurinol should be stopped immediately.If the reaction from the skin is light, then after the disappearance of these changes, you can resume taking allopurinol in a smaller dose (for example, 50 mg per day). Subsequently, the dose can be gradually increased. In case of recurrence of skin reactions, allopurinol therapy should be stopped and no longer restarted, as further administration of the drug may lead to the development of more severe hypersensitivity reactions (see "Immune system disorders").
According to existing information, against the background of therapy with allopurinol, angioedema has developed in isolation, as well as in combination with the symptoms of a generalized hypersensitivity reaction.
Disorders from the musculoskeletal and connective tissue: very rare - myalgia.
Disorders from the kidneys and urinary tract: very rare - hematuria, renal insufficiency, uremia; frequency unknown - urolithiasis disease.
Disorders from the reproductive system and breast: very rare - male infertility, erectile dysfunction, gynecomastia.
General disorders and disorders at the injection site: very rare - edema, general malaise, general weakness, fever.
According to existing information, against the background of therapy with allopurinol, fever developed both in isolation and in combination with the symptoms of a generalized hypersensitivity reaction (see "Immune system disorders").
Reports of possible adverse reactions
In case of adverse reactions, including those not indicated in this manual, the use of the drug should be discontinued.
In the post-marketing period, any information on possible adverse reactions is important, since these reports help to constantly monitor the drug's safety. Health care professionals are required to report any suspicions of adverse reactions to local pharmacovigilance authorities.